相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infection of Prions and Treatment of PrP106-126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway
Qi Shi et al.
MOLECULAR NEUROBIOLOGY (2014)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2
Franc Llorens et al.
PRION (2013)
α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
Brit Mollenhauer et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β
Justin M. Nussbaum et al.
NATURE (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
The contribution of different prion protein types and host polymorphisms to clinicopathological variations in Creutzfeldt-Jakob disease
Mark W. Head et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Gene Knockout of tau Expression Does Not Contribute to the Pathogenesis of Prion Disease
Victoria A. Lawson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease
Ayodeji A. Asuni et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases
Gui-Rong Wang et al.
BMC INFECTIOUS DISEASES (2010)
Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases
Rodrigo Morales et al.
JOURNAL OF NEUROSCIENCE (2010)
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
Anna Ladogana et al.
JOURNAL OF NEUROLOGY (2009)
A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans
Robert Siman et al.
JOURNAL OF NEUROTRAUMA (2009)
Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins
Esperanza Fernandez et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes
K. Gmitterova et al.
NEUROBIOLOGY OF AGING (2009)
Prions: Protein Aggregation and Infectious Diseases
Adriano Aguzzi et al.
PHYSIOLOGICAL REVIEWS (2009)
The expanding realm of prion phenomena in neurodegenerative disease
Bess Frost et al.
PRION (2009)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Specificity and regulation of casein kinase-mediated phosphorylation of α-synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Tauopathy in human and experimental variant Creutzfeldt-Jakob disease
G. Giaccone et al.
NEUROBIOLOGY OF AGING (2008)
Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro
Xiao-Fan Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human α-synuclein:: Implication for α-synucleinopathies
Aasami Ishii et al.
FEBS LETTERS (2007)
Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
K. Leroy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
The ε isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Straussler-Scheinker disease
Giuseppe Di Fede et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
A sporadic case of Creutzfeldt-Jakob disease with beta-amyloid deposits and alpha-synuclein inclusions
Anne Vital et al.
NEUROPATHOLOGY (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
Constanze Boesenberg-Grosse et al.
BMC NEUROLOGY (2006)
14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages
Yusei Shiga et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2006)
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
EM Blalock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Clusterin solubility and aggregation in Creutzfeldt-Jakob disease
M Freixes et al.
ACTA NEUROPATHOLOGICA (2004)
14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease
T Umahara et al.
ACTA NEUROPATHOLOGICA (2004)
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein
C Hetz et al.
EMBO JOURNAL (2003)
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
M Riemenschneider et al.
MOLECULAR PSYCHIATRY (2003)
Abnormal synaptic protein expression and cell death in murine scrapie
S Sisó et al.
ACTA NEUROPATHOLOGICA (2002)
Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain
HC Baxter et al.
NEUROSCIENCE (2002)
Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease
I Zerr et al.
NEUROLOGY (2000)
Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2000)
分享论文
